Eyepoint Pharmaceuticals Inc (EYPT)vsRevolution Medicines Inc (RVMD)
EYPT
Eyepoint Pharmaceuticals Inc
$11.78
-3.92%
HEALTHCARE · Cap: $1.14B
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Eyepoint Pharmaceuticals Inc generates 926% more annual revenue ($7.61M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. EYPT earns a higher WallStSmart Score of 33/100 (F).
EYPT
Avoid33
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 161.7% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : EYPT
The strongest argument for EYPT centers on Revenue Growth, Debt/Equity. Revenue growth of 161.7% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : EYPT
The primary concerns for EYPT are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
EYPT profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
EYPT carries more volatility with a beta of 1.77 — expect wider price swings.
EYPT is growing revenue faster at 161.7% — sustainability is the question.
EYPT generates stronger free cash flow (-82M), providing more financial flexibility.
Bottom Line
EYPT scores higher overall (33/100 vs 24/100) and 161.7% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Eyepoint Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?